Group A:vitrecomy co-adjuvant intravitreal dexamethasone implant

3 trials

Sponsors

Beijing Tongren Hospital, Beijing Tongren Eye center

Conditions

proliferative diabetic retinopathyrehegmatougenous retinal detachment combined with choroidal detachment

Early Phase 1

The effectiveness of vitrecomy co-adjuvant intravitreal dexamethasone implant for proliferative diabetic retinopathy

RecruitingChiCTR2300072745

Beijing Tongren Eye centerproliferative diabetic retinopathy

Start: 2023-06-25Updated: 2023-06-26

Unknown Phase

The effectiveness of vitrecomy co-adjuvant intravitreal dexamethasone implant for proliferative diabetic retinopathy

Active, not recruitingChiCTR2200059760

Beijing Tongren Hospitalproliferative diabetic retinopathy

Start: 2022-05-20Updated: 2024-04-01

The effectiveness of vitrecomy co-adjuvant intravitreal dexamethasone implant for rehegmatougenous retinal detachment combined with choroidal detachment

Active, not recruitingChiCTR2200060427

Beijing Tongren Hospitalrehegmatougenous retinal detachment combined with choroidal detachment

Start: 2022-05-20Updated: 2024-05-13

Related Papers

The effectiveness of vitrectomy co-adjuvant intravitreal dexamethasone implant on visual outcome in patients with proliferative diabetic retinopathy: study protocol for a prospective randomized controlled trial

Trials2025-02-121 citations